Company · founded 2003
Signum Biosciences (United States)
Boulder, United States · signumbiosciences.com
- Citations, last 5 years
- 69
- Works, last 5 years
- 9
- h-index
- 35
- Scientists listed
- 3
- Grants since 2016
- 11
Grants received
2024–2025 · research · R41
The development of a GMP eDHFR vector to monitor investigational CAR T cell therapies
Derek Miller · Signum Biosciences (United States) · funded by National Institutes of Health
2023–2025 · research · R41
Optimizing the synthesis of[18F]FTMP for commercial distribution
Mark A Sellmyer · Signum Biosciences (United States) · funded by National Institutes of Health
2023–2025 · research · R44
Development of ALM-488 for nerve and ureter visualization during abdominal surgery
Brett J. Berman · Signum Biosciences (United States) · funded by National Institutes of Health
2022–2024 · grant · SB1
Commercialization of ALM-488 for Highlighting Nerves During Image Guided Surgeries
Brett J. Berman · Signum Biosciences (United States) · funded by National Institutes of Health
2019–2022 · research · R44
Development of Fluorescent Probes for Highlighting Nerves During Image Guided Surgeries
Brett J. Berman · Signum Biosciences (United States) · funded by National Institutes of Health
2019–2020 · research · R33
Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.
Dean M Scholl · Signum Biosciences (United States) · funded by National Institutes of Health
2019–2021 · research · R33
Title: Development of Modified R-type Bacteriocins to Specifically Target C. difficileand Prevent Relapse of CDIs.
Dean M Scholl · Signum Biosciences (United States) · funded by National Institutes of Health
2019–2022 · research · R44
Development of Fluorescent Probes for Highlighting Nerves During Image Guided Surgeries
Brett J. Berman · Signum Biosciences (United States) · funded by National Institutes of Health
2017–2020 · research · R44
A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis
Edwardo Eddie Perez · Signum Biosciences (United States) · funded by National Institutes of Health
2017–2021 · research · R44
A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis
Edwardo Eddie Perez · Signum Biosciences (United States) · funded by National Institutes of Health
2017–2020 · research · R44
A Topical Non-steroidal Anti-inflammatory for Atopic Dermatitis
Edwardo Eddie Perez · Signum Biosciences (United States) · funded by National Institutes of Health